FDA Inspection 1230349 — LifeCell Corporation
The FDA completed an inspection of LifeCell Corporation on May 21, 2024 in Branchburg, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 21, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Branchburg, NJ (United States)